William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
LENZ Therapeutics (LENZ) Completes Merger with Graphite Bio, Provides Update
-
LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress
-
Whistleblower Secures $70MM Settlement for Alleged Municipal Bond Fraud and Price-Fixing
-
William Blair Starts Neurogene (NGNE) at Outperform, 'The Goldilocks of Gene Therapy'
-
Stevanato Group S.p.A. (STVN) Announces $300M Share Offering
-
Stevanato Group Announces Public Offering of Ordinary Shares
-
SharkNinja (SN) Announces Pricing of Secondary Offering of Ordinary Shares
-
SharkNinja Announces Pricing of Secondary Offering of Ordinary Shares
-
Maxim Group Hires Tom Forte as Managing Director and Senior Consumer Internet Analyst
-
William Blair Out Positive on Carnival Corporation (CCL) Ahead of Earnings
-
Carlisle Cos. (CSL) to Acquire MTL Holdings
-
Carlisle Companies to Acquire MTL Holdings, a Leader in Edge Metal and Non-Insulated Architectural Wall Systems
-
Sensor Tower acquires market intelligence platform data.ai
-
Senegal's election: What is at stake for investors?
-
SharkNinja (SN) selling shareholders to offer ~4.7M shares
-
SharkNinja Announces Launch of Secondary Offering of Ordinary Shares
-
NexPoint Funds Trustee Dorri McWhorter Recognized on List of Top Women in Mutual Fund Governance Space
-
Nordic Capital to invest in leading digital insurance payments network One Inc to drive continued growth and product innovation
-
BharCap Partners Acquires Insurvia
-
Pace(R) Life Sciences Acquires New Jersey Laboratory From Curia
-
Form N-CEN WILLIAM BLAIR FUNDS For: Dec 31
-
William Blair Upgrades Cellebrite (CLBT) to Outperform on 'ew Unified C2C Platform and Recent Government Software M&A'
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Dec 31
-
William Blair Starts Zevra Therapeutics, Inc. (ZVRA) at Outperform
-
William Blair Upgrades Oracle (ORCL) to Outperform, 'Sustained Growth Acceleration'
-
Frazier Healthcare Partners Announces Acquisition of RevSpring
-
Transom Capital Announces Strategic Sale of Aspen Publishing to UWorld, LLC
-
The L.S. Starrett Company (SCX) Enters Into a Merger Agreement With MiddleGround Capital to Become Private Company
-
The L.S. Starrett Company Enters Into a Merger Agreement With MiddleGround Capital to Become Private Company
-
Holding(s) in Company
-
Form NPORT-P/A WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P/A WILLIAM BLAIR FUNDS For: Sep 30
-
William Blair Upgrades HCI Group (HCI) to Outperform, 'Good Opportunity Within Dynamic Homeowners Segment'
-
Nayax (NYAX) Prices 3.13M Share Offering at $26/sh
-
US labor market cooling; unemployment rate rises to two-year high of 3.9%
-
Nayax Announces Pricing of Public Offering
-
Nayax Announces Proposed Public Offering
-
William Blair Defending Ferguson Plc. (FERG), 'Buying Opportunity on Slight EPS Miss'
-
Charlesbank Capital Partners Acquires EverDriven Technologies From Palladium Equity Partners
-
Haemonetics (HAE) to Acquire Attune Medical
-
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
-
QT Imaging Holdings Announces Completion of Business Combination with GigCapital5
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
William Blair Starts Rekor Systems (REKR) at Outperform, 'Large Market Opportunity and Improving Margin Profile'
-
William Blair Reiterates Underperform Rating on Palantir Technologies Inc. (PLTR)
-
GigCapital5, Inc. Announces Closing Date for Business Combination With QT Imaging
-
William Blair Upgrades Korn/Ferry (KFY) to Outperform Ahead of Earnings
-
William Blair Downgrades Societal CDMO, Inc. (SCTL) to Market Perform
-
Janux Therapeutics (JANX) Prices $296.5M Share and Warrant Offering at $46.50/sh
-
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

